Coiled-coil based drug-free macromolecular therapeutics: In vivo efficacy

Journal of Controlled Release

Volumn 157, Issue 1, 2012, Pages 126-131

  Wu, Kuangshi ^a   Yang, Jiyuan ^a   Liu, Jihua ^a   Kopeček, Jindřich ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b Department of Electrical and Computer Engineering   (United States)

Author keywords

Apoptosis; B cell lymphoma; CD20; Coiled coils; Polymer peptide conjugates

Indexed keywords

ANIMAL MODEL; B CELLS; B-CELL LYMPHOMA; CANCER THERAPY; CD20; COILED COIL; HETERODIMERS; HPMA COPOLYMERS; IN-VIVO; INTRAVENOUS ADMINISTRATION; LOW MOLECULAR WEIGHT DRUGS; MACROMOLECULAR THERAPEUTICS; METHACRYLAMIDES; POLYMER-PEPTIDE CONJUGATES;

CELL DEATH; CELL MEMBRANES; COPOLYMERS; DISEASES; MOLECULAR RECOGNITION; ONCOLOGY; PEPTIDES; PHYSIOLOGICAL MODELS;

DRUG THERAPY;

ANTINEOPLASTIC AGENT; CCE PROTEIN; CD20 ANTIBODY; CHOLECYSTOKININ; HETERODIMER; IMMUNOGLOBULIN F(AB) FRAGMENT; N (2 HYDROXYPROPYL)METHACRYLAMIDE COPOLYMER; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CANCER SURVIVOR; CANCER THERAPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; MACROMOLECULE; MOUSE; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; RAJI CELL; SINGLE DRUG DOSE; XENOGRAFT;

AMINO ACID SEQUENCE; ANIMALS; BURKITT LYMPHOMA; CELL LINE, TUMOR; DIMERIZATION; FEMALE; HUMANS; MICE; MICE, SCID; MOLECULAR SEQUENCE DATA; MULTIPROTEIN COMPLEXES; PEPTIDE FRAGMENTS; TREATMENT OUTCOME; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84855852603     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.08.002     Document Type: Article

References (46)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray, and M.J. Thun Cancer statistics, 2008 CA Cancer J. Clin 58 2008 71 96 (Pubitemid 351521864)
2. B.D. Cheson, and J.P. Leonard Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma N. Engl. J. Med. 359 2008 613 626
3. J.O. Armitage, and D.D. Weisenburger New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project J. Clin. Oncol. 16 1998 2780 2795 (Pubitemid 28363044)
4. A. Molina A decade of Rituximab: improving survival outcomes in non-Hodgkin's lymphoma Annu. Rev. Med. 59 2008 237 250 (Pubitemid 351291630)
5. O.W. Press, A.G. Farr, K.I. Borroz, S.K. Anderson, and P.J. Martin Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies Cancer Res. 49 1989 4906 4912 (Pubitemid 19213646)
6. W. Riaz, F.J. Hernandez-Ilizaliturri, and M.S. Czuczman Strategies to enhance rituximab anti-tumor activity in the treatment of CD20-positive B-cell neoplasms Immunol. Res. 46 2010 192 205
7. T.F. Tedder, G. McIntyre, and S.F. Schlossman Heterogeneity in the B1 (CD20) cell surface molecule expressed by human B-lymphocytes Mol. Immunol. 25 1988 1321 1330 (Pubitemid 19023146)
8. T.F. Tedder, and P. Engel CD20: a regulator of cell-cycle progression of B lymphocytes Immunol. Today 15 1994 450 454 (Pubitemid 24272191)
9. O.W. Press, F. Appelbaum, J.A. Ledbetter, P.J. Martin, J. Zarling, P. Kidd, and E.D. Thomas Monoclonal antibody 1 F5 (anti-CD20) serotherapy of human B cell lymphomas Blood 69 1987 584 591 (Pubitemid 17022032)
10. K.C. Anderson, M.P. Bates, B.L. Slaugenhoupt, G.S. Pinkus, S.F. Schlossman, and L.M. Nadler Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation Blood 63 1984 1424 1433 (Pubitemid 14120390)
11. J.T. Golay, E.A. Clark, and P.C. Beverley The CD20 (Bp35) antigen is involved in activation of B cells from the G0 to the G1 phase of the cell cycle J. Immunol. 135 1985 3795 3801 (Pubitemid 16250349)
12. 2+ conductance found constitutively in B lymphocytes J. Cell Biol. 121 1993 1121 1132 (Pubitemid 23154272)
13. J.P. Deans, H. Li, and M.J. Polyak CD20-mediated apoptosis: signalling through lipid rafts Immunology 107 2002 176 182 (Pubitemid 35279043)
14. D. Shan, J.A. Ledbetter, and O.W. Press Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies Blood 91 1998 1644 1652 (Pubitemid 28110329)
15. J.K. Hofmeister, D. Cooney, and K.M. Coggeshall Clustered CD20 induced apoptosis: src-family kinase, the proximal regulator of tyrosine phosphorylation, calcium influx, and caspase 3-dependent apoptosis Blood Cells Mol. Dis. 26 2000 133 143 (Pubitemid 30604893)
16. M.A. Ghetie, H. Bright, and E.S. Vitetta Homodimers but not monomers of Rituxan (chimeric anti-CD20) induce apoptosis in human B-lymphoma cells and synergize with a chemotherapeutic agent and an immunotoxin Blood 97 2001 1392 1398 (Pubitemid 32183764)
17. N. Zhang, L.A. Khawli, P. Hu, and A.L. Epstein Generation of rituximab polymer may cause hyper-cross-linking-induced apoptosis in non-Hodgkin's lymphomas Clin. Cancer Res. 11 2005 5971 5980 (Pubitemid 41170328)
18. M.E. Reff, K. Carner, K.S. Chambers, P.C. Chinn, J.F. Leonard, R. Raab, R.A. Newman, N. Hanna, and D.R. Anderson Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20 Blood 83 1994 435 445 (Pubitemid 24030569)
19. P. McLaughlin, A.J. Grillo-López, B.K. Link, R. Levy, M.S. Czuczman, M.E. Williams, M.R. Heyman, I. Bence-Bruckler, C.A. White, F. Cabanillas, V. Jain, A.D. Ho, J. Lister, K. Wey, D. Shen, and B.K. Dallaire Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program J. Clin. Oncol. 16 1998 2825 2833 (Pubitemid 28363048)
20. P. McLaughlin, C.A. White, A.J. Grillo-López, and D.G. Maloney Clinical status and optimal use of rituximab for B-cell lymphomas Oncology (Williston Park) 12 1998 1763 1769 discussion 1769-1770, 1775-1777
21. J. Boye, T. Elter, and A. Engert An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab Ann. Oncol. 14 2003 520 535 (Pubitemid 41295078)
22. D.G. Maloney Mechanism of action of rituximab Anticancer Drugs 12 Suppl 2 2001 S1 S4
23. P. Johnson, and M. Glenie The mechanism of action of rituximab in the elimination of tumor cells Semin. Oncol. 30 1 Suppl. 2 2003 3 8 (Pubitemid 36337346)
24. J. Kopeček Smart and genetically engineered biomaterials and drug delivery systems Eur. J. Pharm. Sci. 20 2003 1 16 (Pubitemid 37103227)
25. J. Kopeček Hydrogels. From soft contact lenses and implants to self-assembled nanomaterials J. Polym. Sci. A1 Polym. Chem. 47 2009 5929 5946
26. J. Kopeček, and J. Yang Peptide-directed self-assembly of hydrogels Acta Biomater. 5 2009 805 816
27. P.C. Griffiths, A. Paul, B. Apostolovic, H.-A. Klok, E. de Luca, S.M. King, and R.K. Heenan Conformational consequences of cooperative binding of a coiled-coil peptide motif to poly(N-(2-hydroxypropyl) methacrylamide) HPMA copolymers J. Control. Release 153 2011 173 179
28. C. Wang, R.J. Stewart, and J. Kopeček Hybrid hydrogels assembled from synthetic polymers and coiled-coil protein domains Nature 397 1999 417 420
29. J. Yang, C. Xu, C. Wang, and J. Kopeček Refolding hydrogels self-assembled from HPMA graft copolymers by antiparallel coiled-coil formation Biomacromolecules 7 2006 1187 1195 (Pubitemid 43670805)
30. J. Yang, K. Wu, Č. Koňák, and J. Kopeček Dynamic light scattering study of the self-assembly of HPMA hybrid graft copolymers Biomacromolecules 9 2008 510 517 (Pubitemid 351298471)
31. K. Wu, J. Liu, R.N. Johnson, J. Yang, and J. Kopeček Drug-free macromolecular therapeutics: Induction of apoptosis by coiled-coil-mediated cross-linking of antigens on the cell surface Angew. Chem. Int. Ed. 49 2010 1451 1455
32. R.N. Johnson, P. Kopečková, and J. Kopeček Synthesis and evaluation of multivalent branched HPMA copolymer-Fab′ conjugates targeted to B-cell antigen CD20 Bioconjugate Chem. 20 2009 129 137
33. M.A. Ghetie, K. Tucker, J. Richardson, J.W. Uhr, and E.S. Vitteta The antitumor activity of an anti-CD22 Immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxin Blood 80 1992 2315 2320
34. G.L. Griffiths, M.J. Mattes, R. Stein, S.V. Govindan, I.D. Horak, H.J. Hansen, and D.M. Goldenberg Cure of SCID mice bearing human B-lymphoma xenografts by an anti-CD74 antibody-anthracycline conjugate Clin. Cancer Res. 9 2003 6567 6571 (Pubitemid 38031846)
35. W.C. Chen, G.C. Completo, D.S. Sigal, P.R. Crocker, A. Saven, and J.C. Paulson In vivo targeting of B-cell lymphoma with glycan ligands of CD22 Blood 115 2010 4778 4786
36. Y. Li, R.J. Schutte, A. Abu-Shakra, and W.M. Reichert Protein array method for assessing in vitro biomaterial-induced cytokine expression Biomaterials 26 2005 1081 1085 (Pubitemid 39286818)
37. F.J. Hernandez-Ilizaliturri, V. Jupudy, J. Ostberg, E. Oflazoglu, A. Huberman, E. Repasky, and M.S. Czuczman Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model Clin. Cancer Res. 9 2003 5866 5873 (Pubitemid 38018069)
38. B. Říhová, J. Kopeček, K. Ulbrich, J. Pospíšil, and P. Mančal Effect of the chemical structure of N-(2-hydroxypropyl)methacrylamide copolymers on their ability to induce antibody formation in inbred strains of mice Biomaterials 5 1984 143 148
39. B. Říhová, J. Kopeček, K. Ulbrich, and V. Chytrý Immunogenicity of N-(2-hydroxypropyl)methacrylamide copolymers Makromol. Chem. Suppl. 9 1985 13 24
40. J. Šimečková, B. Říhová, D. Plocová, and J. Kopeček Activity of complement in the presence of N-(2-hydroxypropyl)methacrylamide copolymers J. Bioact. Compat. Polym. 1 1986 20 31
41. P. Hart, P. Kopečková, V. Omelyanenko, E. Enoutina, and J. Kopeček HPMA copolymer-modified avidin: immune response J. Biomater. Sci. Polym. Ed. 11 2000 1 12 (Pubitemid 30072032)
42. J. Kopeček Controlled biodegradability of polymers - a key to drug delivery systems Biomaterials 5 1984 19 25 (Pubitemid 14151099)
43. D.A. Goodwin, and C.F. Meares Pretargeting Cancer 80 1997 2675 2680
44. D.A. Goodwin, and C.F. Meares Advances in pretargeting technology Biotechnol. Adv. 19 2001 435 450
45. J. He, G. Liu, S. Gupta, Y. Zhang, M. Rusckowski, and D.J. Hnatowich Amplification targeting: A modified pretargeting approach with potential for signal amplification - proof of a concept J. Nucl. Med. 45 2004 1087 1095 (Pubitemid 47611697)
46. R.M. Sharkey, H. Karacay, S. Litwin, E.A. Rossi, W.J. McBride, C.-H. Chang, and D.M. Goldenberg Improved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant, trivalent, anti-CD20, bispecific antibody Cancer Res. 68 2008 5282 5290